FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2415939905> ?p ?o ?g. }

• W2415939905 endingPage "52" @default.
• W2415939905 startingPage "346" @default.
• W2415939905 abstract "Prostate-specific antigen levels are used to judge disease control of prostate cancer. No published data attest to the greater ability of conformal brachytherapy to control disease compared with conventional radiation at a single institution. This report compares the biochemical response rates in patients with stages T2b to T3c prostate cancer treated with conformal brachytherapy boost and external beam radiation with the rates in patients treated with conventional external radiation alone.From November 1991 through November 1995, 58 patients received 45.6 Gy pelvic external irradiation and three high dose rate iridium-192 conformal boost implants of 5.5 to 6.5 Gy each. They were compared with 278 similarly staged patients treated from January 1987 through December 1991 with external beam radiation to prostate-only fields (median dose 66.6 Gy). No patient received androgen deprivation. Patient outcome was analyzed for biochemical control. Biochemical failure was defined as a prostate-specific antigen level > 1.5 ng/mL and rising on two consecutive values. If serial posttreatment prostate-specific antigen levels were showing a continuous downward trend, failure was not scored.Median follow-up was 43 months for the conventionally treated group and 26 months for the brachytherapy boost group. The median pretreatment prostate-specific antigen level was 14.3 ng/mL for the external-beam-radiation-alone group and 14.0 ng/mL for the brachytherapy boost group. The median Gleason scores were 6 and 7, respectively, for the two groups. The biochemical control rate was significantly higher in the brachytherapy boost treatment group. Three-year actuarial biochemical control rates were 85% versus 52% for the conformally and conventionally treated patients, respectively. In a multivariate analysis, the use of conformal brachytherapy boost and pretreatment prostate-specific antigen level were significant prognostic determinants of biochemical control. The 3-year actuarial rates of biochemical control for conformally versus conventionally treated patients, respectively, were 83% versus 72% for a pretreatment prostate-specific antigen level of 4.1 to 10.0 ng/mL, 85% versus 47% for a prostate-specific antigen level of 10.1 to 20.0 ng/mL, and 89% versus 29% for prostate-specific antigen > 20 ng/mL. When the analysis was limited to patients in both groups with a minimum 12-month follow-up, the brachytherapy boost group continued to show a higher biochemical control rate compared with the conventional radiation group (3-year actuarial rates of 86% vs 53%).These preliminary results show a significant improvement in the biochemical response rate with conformal boost brachytherapy and pelvic external radiation compared with conventional radiation alone. These results, coupled with our previously reported acceptable toxicity rates, support the use of this technique." @default.
• W2415939905 created "2016-06-24" @default.
• W2415939905 creator A5001291619 @default.
• W2415939905 creator A5006101201 @default.
• W2415939905 creator A5010954841 @default.
• W2415939905 creator A5016407136 @default.
• W2415939905 creator A5017328433 @default.
• W2415939905 creator A5049646055 @default.
• W2415939905 creator A5061695890 @default.
• W2415939905 creator A5067790465 @default.
• W2415939905 creator A5076339276 @default.
• W2415939905 creator A5084129032 @default.
• W2415939905 date "1997-12-24" @default.
• W2415939905 modified "2023-09-27" @default.
• W2415939905 title "Conformal high dose rate iridium-192 boost brachytherapy in locally advanced prostate cancer: superior prostate-specific antigen response compared with external beam treatment." @default.
• W2415939905 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/9403047" @default.
• W2415939905 hasPublicationYear "1997" @default.
• W2415939905 type Work @default.
• W2415939905 sameAs 2415939905 @default.
• W2415939905 citedByCount "13" @default.
• W2415939905 countsByYear W24159399052013 @default.
• W2415939905 crossrefType "journal-article" @default.
• W2415939905 hasAuthorship W2415939905A5001291619 @default.
• W2415939905 hasAuthorship W2415939905A5006101201 @default.
• W2415939905 hasAuthorship W2415939905A5010954841 @default.
• W2415939905 hasAuthorship W2415939905A5016407136 @default.
• W2415939905 hasAuthorship W2415939905A5017328433 @default.
• W2415939905 hasAuthorship W2415939905A5049646055 @default.
• W2415939905 hasAuthorship W2415939905A5061695890 @default.
• W2415939905 hasAuthorship W2415939905A5067790465 @default.
• W2415939905 hasAuthorship W2415939905A5076339276 @default.
• W2415939905 hasAuthorship W2415939905A5084129032 @default.
• W2415939905 hasConcept C121608353 @default.
• W2415939905 hasConcept C126322002 @default.
• W2415939905 hasConcept C126894567 @default.
• W2415939905 hasConcept C143998085 @default.
• W2415939905 hasConcept C2775908122 @default.
• W2415939905 hasConcept C2776235491 @default.
• W2415939905 hasConcept C2777416452 @default.
• W2415939905 hasConcept C2777899217 @default.
• W2415939905 hasConcept C2778648096 @default.
• W2415939905 hasConcept C2780192828 @default.
• W2415939905 hasConcept C2781406297 @default.
• W2415939905 hasConcept C2989005 @default.
• W2415939905 hasConcept C3020003399 @default.
• W2415939905 hasConcept C509974204 @default.
• W2415939905 hasConcept C71924100 @default.
• W2415939905 hasConceptScore W2415939905C121608353 @default.
• W2415939905 hasConceptScore W2415939905C126322002 @default.
• W2415939905 hasConceptScore W2415939905C126894567 @default.
• W2415939905 hasConceptScore W2415939905C143998085 @default.
• W2415939905 hasConceptScore W2415939905C2775908122 @default.
• W2415939905 hasConceptScore W2415939905C2776235491 @default.
• W2415939905 hasConceptScore W2415939905C2777416452 @default.
• W2415939905 hasConceptScore W2415939905C2777899217 @default.
• W2415939905 hasConceptScore W2415939905C2778648096 @default.
• W2415939905 hasConceptScore W2415939905C2780192828 @default.
• W2415939905 hasConceptScore W2415939905C2781406297 @default.
• W2415939905 hasConceptScore W2415939905C2989005 @default.
• W2415939905 hasConceptScore W2415939905C3020003399 @default.
• W2415939905 hasConceptScore W2415939905C509974204 @default.
• W2415939905 hasConceptScore W2415939905C71924100 @default.
• W2415939905 hasIssue "6" @default.
• W2415939905 hasLocation W24159399051 @default.
• W2415939905 hasOpenAccess W2415939905 @default.
• W2415939905 hasPrimaryLocation W24159399051 @default.
• W2415939905 hasRelatedWork W1981695099 @default.
• W2415939905 hasRelatedWork W2005896027 @default.
• W2415939905 hasRelatedWork W2006521105 @default.
• W2415939905 hasRelatedWork W2027393877 @default.
• W2415939905 hasRelatedWork W2054364997 @default.
• W2415939905 hasRelatedWork W2087149288 @default.
• W2415939905 hasRelatedWork W2138863125 @default.
• W2415939905 hasRelatedWork W2143699516 @default.
• W2415939905 hasRelatedWork W2165532162 @default.
• W2415939905 hasRelatedWork W2415939905 @default.
• W2415939905 hasVolume "3" @default.
• W2415939905 isParatext "false" @default.
• W2415939905 isRetracted "false" @default.
• W2415939905 magId "2415939905" @default.
• W2415939905 workType "article" @default.